Serum acute phase protein and inflammatory cytokine network correlations: Comparison of a pre-rheumatoid arthritis and non-rheumatoid arthritis community cohort

Journal of Innate Immunity

Volumn 5, Issue 2, 2013, Pages 100-113

  Masi, Alfonse T ^a   Rehman, Azeem A ^a   Elmore, Kevin B ^a   Aldag, Jean C ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Acute phase proteins; Case control study; Cytokine receptors; ELISA assays; IL 1ra; Inflammatory cytokines; Pre RA; Principal component analysis; Rheumatoid arthritis

Indexed keywords

ACUTE PHASE PROTEIN; ACUTE PHASE SERUM AMYLOID A; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2 SOLUBLE RECEPTOR ALPHA; INTERLEUKIN 6; RHEUMATOID FACTOR; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; SOLUBLE INTERLEUKIN 2 RECEPTOR;

ADULT; AGE DISTRIBUTION; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARTICIPATORY RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOKING; AGING; MULTIPLE REGRESSION; NON RHEUMATOID ARTHRITIS; PRE RHEUMATOID ARTHRITIS; PRINCIPAL COMPONENT ANALYSIS;

ACUTE-PHASE PROTEINS; ADULT; AGE FACTORS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CELL COMMUNICATION; COHORT STUDIES; CYTOKINES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; RESIDENCE CHARACTERISTICS; SEX FACTORS;

EID: 84876143954     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000345700     Document Type: Article

References (37)

1. Akira S, Hirano T, Taga T, Kishimoto T: Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 1990; 4: 2860-2867.
2. Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, et al: Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlated with disease activity. J Rheumatol 1997; 24: 303-308.
3. Kushner I: Regulation of the acute phase response by cytokines. Perspect Biol Med 1993; 36: 611-622.
4. Abeywardena MY, Leifert WR, Warnes KE, Varghese JN, Head RJ: Cardiovascular biology of interleukin-6. Curr Pharm Des 2009; 15: 1809-1821.
5. Ganapathi MK, Schultz D, Mackiewicz A, Samols D, Hu SI, Brabenec A, Macintyre SS, Kushner I: Heterogeneous nature of the acute phase response: differential regulation of human serum amyloid A, C-reactive protein, and other acute phase proteins by cytokines in Hep 3B cells. J Immunol 1988; 141: 564-569.
6. Badolato R, Oppenheim JJ: Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis. Semin Arthritis Rheum 1996; 26: 526-538.
7. Yao C, Wei W, Li X, Hosoi K: Acute phase protein induction by experimental inflammation in the salivary gland. J Oral Pathol Med 2005; 34: 364-367.
8. Jiang S, Xia D, Samols D: Expression of rabbit C-reactive protein in transgenic mice inhibits development of antigen-induced arthritis. Scand J Rheumatol 2006; 35: 351-355.
9. Hager K, Machein U, Krieger S, Platt D, Seefried G, Bauer J: Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging 1994; 15: 771-772.
10. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE: Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 2000; 55:M709-M715.
11. Masi AT, Aldag JC, Sipe JD, Malamet RL: Women before clinical onset of RA (preRA) had strong correlations of baseline serum IL-6 with VEGF and IL-1 beta with acute serum amyloid A (ASAA) plus soluble TNFreceptor type I (sTNF-RI), not observed in cohort controls (CN). Arthritis Rheum 2006; 54:S203.
12. Jorgensen KT, Wiik A, Pedersen M, Hedegaard CJ, Vestergaard BF, Gislefoss RE, Kvien TK, Wohlfahrt J, Bendtzen K, Frisch M: Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis 2008; 67: 860-866.
13. El-Gabalawy HS, Robinson DB, Smolik I, Hart D, Elias B, Wong K, Peschken CA, Hitchon CA, Li X, Bernstein CN, Newkirk MM, Fritzler MJ: Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients. Arthritis Rheum 2012; 64: 1720-1729.
14. Lannergård A, Larsson A, Kragsbjerg P, Friman G: Correlations between serum amyloid A protein and C-reactive protein in infectious diseases. Scand J Clin Lab Invest 2003; 63: 267-272.
15. Manicourt DH, Triki R, Fukuda K, Devogelaer JP, Nagant de Deuxchaisnes C, Thonar EJ: Levels of circulating tumor necrosis factor alpha and interleukin-6 in patients with rheumatoid arthritis: relationship to serum levels of hyaluronan and antigenic keratin sulfate. Arthritis Rheum 1993; 36: 490-499.
16. van Leeuwen MA, Westra J, Limburg PC, van Riel PL, van Rijswijk MH: Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study. Ann Rheum Dis 1995; 54: 674-677.
17. Cunnane G, Grehan S, Geoghegan S, Mc-Cormack C, Shields D, Whitehead AS, Bresnihan B, Fitzgerald O: Serum amyloid A in the assessment of early inflammatory arthritis. J Rheumatol 2000; 27: 58-63.
18. Lash GE, Scaife PJ, Innes BA, Otun HA, Robson SC, Searle RF, Bulmer JN: Comparison of three multiplex cytokine analysis systems: Luminex, SearchLight and FAST Quant. J Immunol Methods 2006; 309: 205-218.
19. duPont NC, Wang K, Wadhwa PD, Culhane JF, Nelson EL: Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 2005; 66: 175-191.
20. Richens JL, Urbanowicz RA, Metcalf R, Corne J, O'Shea P, Fairclough L: Quantitative validation and comparison of multiplex cytokine kits. J Biomol Screen 2010; 15: 562-568.
21. Churchman SM, Geiler J, Parmar R, Horner EA, Church LD, Emery P, et al: Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factor. Clin Exper Rheumatol 2012; 30: 534-542.
22. Helzlsouer KJ, Alberg AJ, Gordon GB, Longcope C, Bush TL, Hoffman SC, Cornstock GW: Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 1995; 274: 1926-1930.
23. Rothman N, Cantor KP, Blair A, Bush D, Brock JW, Helzlsouer K, Zahm SH, Needham LL, Pearson GR, Hoover RN, Cornstock GW, Strickland PT: A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet 1997; 350: 240-244.
24. Alberg AJ, Gordon GB, Hoffman SC, Comstock GW, Helzlsouer KJ: Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer. Cancer Epidemiol Biomarkers Prev 2000; 9: 517-521.
25. Masi AT, Aldag JC: Integrated neuroendocrine immune risk factors in relation to rheumatoid arthritis: should rheumatologists now adopt a model of a multiyear, presymptomatic phase? Scand J Rheumatol 2005; 34: 342-352.
26. Gerlag DM, Raza K, van Baarsen LG, Brouwer E, Buckley CD, et al: EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis 2012; 71: 638-641.
27. Arnett FC, Edworthy SM, Bloch DA, Mc-Shane DJ, Fries JF, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
28. Masi AT, Feigenbaum SL, Chatterton RT: Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunologic and microvascular systems. Semin Arthritis Rheum 1995; 25: 1-27.
29. Masi AT: Incidence of rheumatoid arthritis: do the observed age-sex interaction patterns support a role of androgenic-anabolic steroid deficiency in its pathogenesis? Br J Rheumatol 1994; 33: 697-699.
30. Shields MJ, Siegel JN, Clark CR, Hines KK, Potempa LA, Gewurz H, Anderson B: An appraisal of polystyrene-(ELISA) and nitrocellulose-based (ELIFA) enzyme immunoassay systems using monoclonal antibodies reactive toward antigenically distinct forms of human C-reactive protein. J Immunol Methods 1991; 141: 253-261.
31. Dixon WJ, Tukey JW: Approximate behavior of the distribution of Winsorized t (Trimming/ Winsorization 2). Technometrics 1968; 10: 83-98.
32. Masi AT, Aldag JC, Sipes J: Do elevated levels of serum C-reactive protein predict rheumatoid arthritis in men: correlations with pre-RA status and baseline positive rheumatoid factors. J Rheumatol 2001; 28: 2359-2361.
33. Nielen MM, van Schaardenburg D, Reesink HW, Twisk JW, van de Stadt RJ, et al: Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis. Arthritis Rheum 2004; 50: 2423-2427.
34. Aho K, Palosuo T, Knekt P, Alha P, Aromaa A, Heliovaara M: Serum C-reactive protein does not predict rheumatoid arthritis. J Rheumatol 2000; 27: 1136-1138.
35. Szklo M, Nieto FJ: Quality assurance and control; in: Epidemiology: Beyond the Basics. Gaithersburg, Aspen, 2000, pp 398-399.
36. Praditpornsilpa K, Avihingsanon Y, Kupatawintu P, Songpanich S, Pisitkul T, Kansanabuch T, Eiam-Ong S, Chusil S, O-Charoen R, Tungsanga K: Monitoring of T-cell subsets in patients treated with anti-CD 25 antibody. Transplant Proc 2004; 36: 487S-491S.
37. Gabay C, Porter B, Guenette D, Billir B, Arend WP: Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1 β on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. Blood 1999; 93: 1299-1307.